• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Eraxis (anidulafungin) for Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) 

 

July 2012

Summary View

WARNINGS AND PRECAUTIONS

Hypersensitivity
  • bronchospasm 

 

 

November 2010 

Summary View

ADVERSE REACTIONS

  • General: bronchospasm